Zabalafin hydrogel (Alphyn Biologics)

N/A

Report date: 2024/08/28 10:01:27
NME

Base Information

Drug NameZabalafin hydrogel (Alphyn Biologics)
Drug Alias NameAB-101AB-101 AD1AB-101 EB1AB-101aAB-101b
ClassificationNatural product/Extract > Plants extractSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytokines inhibitors
TargetsCytokines
Therapy Area/IndicationsEczemaDermatitis, AtopicEpidermolysis Bullosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlphyn Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlphyn Biologics Inc
Inactive CompaniesN/A
Active IndicationsEczemaDermatitis, AtopicEpidermolysis Bullosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A